Your session is about to expire
← Back to Search
Provider Intervention for HIV Care Outcomes
N/A
Recruiting
Led By Lu Dong, PhD
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to immediately after the intervention
Awards & highlights
Study Summary
This trial will develop an online provider intervention to address intersectional stigma & medical mistrust in HIV care, so HIV care providers can better serve Black & Latino Americans. Pilot trial will test acceptability & effects on providers & HIV care outcomes.
Who is the study for?
This trial is for clinical providers like doctors, nurses, and physician assistants who treat HIV patients, particularly those from racial/ethnic and sexual minority groups. They must be able to commit time to the study.Check my eligibility
What is being tested?
The trial is testing an online intervention designed to educate healthcare providers on addressing intersectional stigma and medical mistrust in Black and Latina/Latino Americans with HIV. It's a pilot randomized controlled trial comparing this intervention against no intervention.See study design
What are the potential side effects?
Since this is a provider education program rather than a medical treatment, there are no direct side effects for patients. However, it aims to improve patient care by reducing stigma and mistrust.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to immediately after the intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to immediately after the intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Helpful/empathetic responses toward medial mistrust in hypothetical patient scenarios
Provider use of strategies learned in the provider intervention in a role-play simulation of hypothetical patient scenarios
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Provider InterventionExperimental Treatment1 Intervention
The intervention will consist of psychoeducation and skills-building for HIV care providers to gain the knowledge and skills needed to address intersectional stigma and medical mistrust with patients. The intervention will be online and conducted in groups.
Group II: ControlActive Control1 Intervention
No intervention control
Find a Location
Who is running the clinical trial?
RANDLead Sponsor
137 Previous Clinical Trials
510,191 Total Patients Enrolled
California Prevention Training CenterUNKNOWN
Brigham and Women's HospitalOTHER
1,615 Previous Clinical Trials
11,470,770 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot commit the required time for this trial.I can commit to the schedule required by the study.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Provider Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open spots presently available in this trial?
"Affirmative. According to clinicaltrials.gov, this medical trial commenced on October 15th 2022 and is actively recruiting patients for participation. Currently, 60 individuals are required at one site of the study."
Answered by AI
What is the participant count in this research endeavor?
"Affirmative. Data hosted on clinicaltrials.gov demonstrates that this medical investigation, which was originally posted on October 15th 2022, is actively recruiting individuals. Approximately 60 participants must be enrolled from 1 distinct healthcare facility."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger